Skip to content

The Agenda-Setting for Kidney Disease Open Pilot Trial

Setting the Agenda: An Open Pilot of a Structured Clinical Visit Agenda-Setting Intervention for Rural-Residing People With Advanced Chronic Kidney Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07221604
Acronym
ASK
Enrollment
30
Registered
2025-10-28
Start date
2026-05-19
Completion date
2026-09-01
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease Stage 4

Keywords

Chronic kidney disease, Chronic kidney disease stage 4, Chronic kidney disease stage 5, Agenda-setting, Patient engagement, Rural, Participatory research, Open pilot

Brief summary

The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease (CKD) Topics, and it is a structured clinical agenda-setting intervention (SAS), or a customized list of discussion topics. The people the researchers are practicing using the SAS with have advanced CKD (stages 4-5), and many of them live in rural areas. The researchers will practice administering CKD Topics, along with survey questions. By doing the open pilot, the researchers will learn if they need to modify the steps they plan to take in the larger trial. The main questions the researchers aim to answer are: * Do the steps for identifying eligible participants work? * Do the steps for administering CKD Topics work? * Do the steps to administer survey questions work?

Detailed description

In this open pilot, the researchers will administer a novel structured agenda-setting tool (SAS) called Chronic Kidney Disease (CKD) Topics. The researchers will determine if their procedures for screening eligible participants, administering the intervention, and administering outcome and other questionnaires are appropriate. Learnings from the open pilot will feed forward into procedures in a larger planned pilot stepped wedge feasibility trial. This study only has one arm, the intervention arm. The intervention, CKD Topics, will be administered as a quality improvement intervention. Future Directions: This open pilot will inform procedural changes in an upcoming pilot stepped wedge feasibility trial.

Interventions

Chronic Kidney Disease (CKD) Topics is a novel clinical visit agenda-setting intervention developed through participatory research methods for people with CKD living in rural areas. CKD Topics includes 8 structured discussion topic areas with the option for patients to consider and indicate their priority topic areas and take notes before, during, and after a clinical visit.

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Dartmouth College
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Open feasibility pilot trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults \>18 years old who have been diagnosed with advanced CKD (stages 4-5). * Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent * English-speaking * Able to provide informed consent * Patient must be attending outpatient visits \*(in-person and/or telehealth allowable).

Exclusion criteria

* Children under 18 years old will not be included * Non-English-speaking patients and/or care partners * Patients on dialysis * Individuals unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Primary Feasibility Outcome: Intervention receiptDay 1Our primary outcome will be feasibility, assessed by the proportion of patients who received the intervention.

Countries

United States

Contacts

CONTACTCatherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH
Catherine.Hylas.Saunders@dartmouth.edu603-653-3436
CONTACTAnne E. Dade, Research Associate, MPP
anne.e.dade@dartmouth.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026